A RETROSPECTIVE STUDY TO EVALUATE HRCT FINDINGS OF COVID 19 PATIENTS AND ITS CORRELATION WITH CLINICAL MANIFESTATIONS
European Journal of Molecular & Clinical Medicine,
2023, Volume 10, Issue 2, Pages 1198-1206
AbstractTo investigate and quantify the severity of COVID-19 infection on HRCT and to determine its relationship with clinical profile and outcome.
Material And Methods-
Study population- 95 COVID-19 positive patients who were hospitalised to J A
Group of Hospitals & SSH, Gwalior, M.P were taken for retrospective analysis , referred to Department of Radiodiagnosis for HRCT evaluation.
In our study group most of patients were in fifth and sixth decade with mean age 47 year, majority of patients are male, (52.63%) patients were symptomatic, whereas (13.68%) were asymptomatic. Fever and cough were the most frequent presenting symptoms in symptomatic patients, followed by shortness of breath, chest pain and myalgia, sore throat and headache. Approx. 26.4% of patients had an underlying co-morbid condition with diabetes mellitus, hypertension were the most common co-morbidities seen. Along with ground glass opacity(GGO) , COVID-19 patients also showed some nonspecific findings like pleural effusion, mediastinal lymphadenopathy.
The diverse COVID-19 spectrum included symptoms such as fever, coughing, shortness of breath, sore throat, etc. Major concomitant conditions were CAD, COPD/K-Chest, hypertension, diabetes mellitus, and hypertension. Positive CT findings were more noticeable in symptomatic patients and patients with co-morbid conditions, giving HRCT chest in COVID-19 patients significant diagnostic and prognostic significance. CT imaging is important for monitoring patients' clinical progress. The findings of this study supported the
importance of chest CT in the identification and treatment of COVID-19 infection.
- Article View: 5
- PDF Download: 39